The nation’s ability to test for COVID-19 has expanded, thanks to work at Pacific Northwest National Laboratory, where scientists have established the performance of testing equipment to detect the virus.
Researchers from PNNL have helped colleagues at OHSU identify lipid molecules required for Zika infection in human cells. The specific lipids involved could also be a clue to why the virus primarily infects brain tissue.
A technology that can quickly detect explosive vapors, deadly chemicals and illicit drugs with unparalleled accuracy has been named the 2020 Innovation of the Year by GeekWire, the Seattle-based technology news company.
A multi-institution research team found how the protein environment surrounding some enzymes can alter the direction of a cellular reaction, as well as its rate—up to six orders of magnitude—in a phenomenon referred to as catalytic bias.
New technique galvanizes iron-based nanoparticles to create an exceptional catalyst. PNNL researchers describe a new technique that produces metal nanoparticles supported on solid iron oxide, in one step, at near room temperature.
To help spur economic development and assist in the battle against COVID-19, PNNL is making available its entire portfolio of patented technologies on a research trial basis—at no cost—through the end of 2020.
A long-standing collaboration between PNNL and Oregon State University to study harmful chemicals at federally designated hazardous waste sites primarily across the Pacific Northwest has been awarded a five-year, $12.7 million grant.
The recent coronavirus pandemic shows just how quickly a deadly pathogen can sweep across the globe, killing tens of thousands in the U.S. and disrupting daily life for millions more in the span of a few months.
A PNNL scientist is studying the structures of the proteins on the surface of the novel coronavirus, using NMR spectroscopy to reveal information about the molecular toolkit that holds the keys to a vaccine or treatment.